For the year ending 2025-12-31, ARDT had $152,816K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 230,135 |
| Depreciation and amortization | 155,703 |
| Other non-operating losses (gains) | 1,275 |
| Loss on extinguishment and modification of debt | -515 |
| Amortization of deferred financing costs and debt discounts | 4,379 |
| Deferred income taxes | 43,594 |
| Equity-based compensation | 39,293 |
| (income) loss from non-consolidated affiliates | 1,043 |
| Accounts receivable | -59,155 |
| Inventories | 3,148 |
| Prepaid expenses and other current assets | 122,094 |
| Accounts payable and other accrued expenses and liabilities | 62,060 |
| Accrued salaries and benefits | 686 |
| Net cash provided by operating activities | 470,510 |
| Investment in acquisitions, net of cash acquired | 2,504 |
| Purchases of property and equipment | 211,904 |
| Proceeds from divestitures | 0 |
| Other | -179 |
| Net cash used in investing activities | -214,229 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 0 |
| Proceeds from revolving line of credit | 0 |
| Proceeds from insurance financing arrangements | 15,607 |
| Proceeds from long-term debt | 0 |
| Payments of principal on revolving line of credit | 0 |
| Payments of principal on insurance financing arrangements | 15,041 |
| Payments of principal on long-term debt | 7,988 |
| Debt issuance costs | 2,573 |
| Payments of initial public offering costs | 0 |
| Distributions to noncontrolling interests | 88,239 |
| Redemption of equity attributable to noncontrolling interests | 0 |
| Other | -5,231 |
| Net cash (used in) provided by financing activities | -103,465 |
| Net increase (decrease) in cash and cash equivalents | 152,816 |
| Cash and cash equivalents, beginning balance | 556,785 |
| Cash and cash equivalents, ending balance | 709,601 |
Ardent Health, Inc. (ARDT)
Ardent Health, Inc. (ARDT)